News & Events
2011
-
August 4, 2011Mexican health authority has granted marketing authorization for pitavastatin，an HMG-CoA reductase inhibitor or statin，for treatment of hyperlipidemia. Kowa’s partner，Eli Lilly will market the product as RedevantR from early 2012.
-
May 11, 2011The HMG-CoA reductase inhibitor pitavastatin calcium (Livazo 1mg, 2mg & 4mg) has been launched in Spain on May 2, 2011 as the first European market.
Spain is co-marketed by Recordati S.p.A and ESTEVE -
January 19, 2011Peretinoin (NIK-333) Study Subanalysis Gives Clue To Mechanism of Reduced Recurrence of Hepatocellular Carcinoma (HCC), To Be Presented at American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2011